Abion Inc.

KQ:203400 Korea Biotechnology
Market Cap
$125.58 Million
₩183.88 Billion KRW
Market Cap Rank
#19423 Global
#779 in Korea
Share Price
₩2960.00
Change (1 day)
-2.15%
52-Week Range
₩2500.00 - ₩12840.00
All Time High
₩24999.35
About

ABION Inc. operates as a pharmaceutical biotech Company in South Korea and internationally. The company develops anticancer therapeutic drugs, such as ABN401, a tyrosine kinase inhibitor that is in Phase II clinical trials for treating non-small cell lung cancer, as well as in Phase I clinical trial for breast cancer; ABN501, a human monoclonal antibody that targets claudin 3 for treating solid c… Read more

Abion Inc. (203400) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: -0.336x

Based on the latest financial reports, Abion Inc. (203400) has a cash flow conversion efficiency ratio of -0.336x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.91 Billion) by net assets (₩11.65 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Abion Inc. - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Abion Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Abion Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Abion Inc. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Abion Inc. (2016–2024)

The table below shows the annual cash flow conversion efficiency of Abion Inc. from 2016 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩28.13 Billion ₩-28.06 Billion -0.997x +63.03%
2023-12-31 ₩9.98 Billion ₩-26.92 Billion -2.698x -104.83%
2022-12-31 ₩15.10 Billion ₩-19.89 Billion -1.317x -349.48%
2021-12-31 ₩32.10 Billion ₩-9.41 Billion -0.293x -161.05%
2020-12-31 ₩-20.04 Billion ₩-9.62 Billion 0.480x -19.58%
2019-12-31 ₩-11.01 Billion ₩-6.57 Billion 0.597x +122.35%
2018-12-31 ₩2.46 Billion ₩-6.57 Billion -2.671x +11.62%
2017-12-31 ₩2.91 Billion ₩-8.79 Billion -3.022x -164.15%
2016-12-31 ₩5.36 Billion ₩-6.14 Billion -1.144x --